Table 1.
Thirteen Guidelines Selected for Adaptation
Author | Title | Country | Journal | Year | Volume/page |
---|---|---|---|---|---|
Farraye et al. [5] | ACG clinical guideline: preventive care in inflammatory bowel disease | USA | American Journal of Gastroenterology | 2017 | 112/241-258 |
Rahier et al. [2] | Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease | Europe | Journal of Crohn's and Colitis | 2014 | 8/443-468 |
European Association for the Study of the Liver [6] | EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection | Europe | Journal of Hepatology | 2017 | 67/370-398 |
European Association for the Study of the Liver [7] | EASL recommendations on treatment of hepatitis C 2018 | Europe | Journal of Hepatology | 2018 | 69/461-511 |
Terrault et al. [8] | Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance | USA | Hepatology | 2018 | 67/1560-1599 |
Korean Association for the Study of the Liver (KASL) [9] | 2017 KASL clinical practice guidelines management of hepatitis C: treatment of chronic hepatitis C | Korea | Clin Mol Hepatol | 2018 | 24/169-229 |
Korean Association for the Study of the Liver (KASL) [10] | KASL clinical practice guidelines for management of chronic hepatitis B | Korea | Clin Mol Hepatol | 2019 | 25/93-159 |
Singh et al. [11] | 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis | USA | Arthritis Care & Research | 2016 | 68/1-25 |
Rubin et al. [12] | 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host | USA | Clinical Infectious Diseases | 2014 | 58/309-318 |
Bombardier et al. [13] | Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease- modifying antirheumatic drugs: part II safety | Canada | The Journal of Rheumatology | 2012 | 39/1583-1602 |
van Assen et al. [14] | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases | Europe | Annals of the Rheumatic Disease | 2011 | 70/414-422 |
Bühler et al. [15] | Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases | Swiss | Swiss Medical Weekly | 2015 | 145/W14159 |
Cordeiro et al. [16] | Recommendations for vaccination in adult patients with systemic inflammatory rheumatic diseases from the Portuguese Society of Rheumatology | Portugal | Acta Reumatológica Portuguesa | 2016 | 41/112-130 |
ACG, American College of Gastroenterology; EASL, European Association for the Study of the Liver; AASLD, American Association for the Study of Liver Disease; KASL, Korean Association for the Study of the Liver; IDSA, Infectious Disease Society of America; EULAR, European League Against Rheumatism.